Literature DB >> 16728359

Incidence of hereditary spherocytosis in a population of jaundiced neonates.

Véronique Saada1, Thérèse Cynober, Yves Brossard, Pierre Olivier Schischmanoff, Alfred Sender, Henri Cohen, Jean Delaunay, Gil Tchernia.   

Abstract

As most of hereditary spherocytosis-affected individuals experience jaundice at birth, it seemed of interest to evaluate the proportion of hereditary spherocytosis in 402 severely jaundiced neonates with a bilirubinemia level prompting phototherapy. Red cell dehydration, a hallmark of spherocytosis whether constitutional or acquired, was demonstrated in 74 of them, among whom 23 disclosed a typical pattern of spherocytosis upon red cell deformability studies. Acquired spherocytosis of immune origin was diagnosed in 19/23 and hereditary spherocytosis in 4, making the proportion of hereditary spherocytosis-affected individuals among a severely jaundiced population of neonates amount to 1%, an incidence at least 30-fold that of the overall population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728359     DOI: 10.1080/08880010600646662

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

Review 1.  A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.

Authors:  Robert D Christensen; Hassan M Yaish; Patrick G Gallagher
Journal:  Pediatrics       Date:  2015-06       Impact factor: 7.124

2.  Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.

Authors:  R D Christensen; A M Agarwal; R H Nussenzveig; N Heikal; M A Liew; H M Yaish
Journal:  J Perinatol       Date:  2014-11-06       Impact factor: 2.521

3.  Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A.

Authors:  Ashley M Toye; Rosalind C Williamson; Moudji Khanfar; Brigitte Bader-Meunier; Thérèse Cynober; Madeleine Thibault; Gil Tchernia; Michèle Déchaux; Jean Delaunay; Lesley J Bruce
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.